Quick Overview
- Conagra Brands directors acquired a total of 42,500 shares on April 14, deploying approximately $609,000 as the stock traded close to its yearly bottom.
- The stock has declined 17% during 2026, pressured by shrinking sales volumes, squeezed margins, and reduced forward guidance.
- Fiscal third-quarter results disappointed with earnings per share of $0.39 versus the expected $0.40, while sales dropped 1.9% compared to last year.
- Morgan Stanley lowered its valuation target to $15 from $17 this week while maintaining an “equal weight” stance.
- Wall Street’s collective view leans toward “Reduce” with a $15.80 average price objective — 1 Buy rating, 13 Holds, and 4 Sells.
Two board members at Conagra recently demonstrated conviction by making significant stock purchases. On April 14, Director Richard H. Lenny acquired 25,000 shares at a price of $14.34 per share, totaling $358,500. Fellow Director John J. Mulligan purchased 17,500 shares at $14.31 apiece that same trading session, investing $250,425.
Together, the purchases totaled approximately $609,000 and occurred while shares traded near the 12-month floor of $14.04. Mulligan’s buy increased his stake by a remarkable 542%. Lenny’s holdings now stand at 229,340 shares with a market value approaching $3.3 million.
The context surrounding these transactions is notable. CAG began its recent slide on April 9 following a BNP Paribas downgrade from Outperform to Neutral, accompanied by a price target reduction to $16 from $19. Shares broke below $16 that very session.
The situation intensified further. On April 13, Conagra announced John Brase as its incoming CEO and president. Jefferies noted that Brase faces challenging conditions including “high leverage, ongoing inflationary pressures, and margin compression.”
Disappointing Quarterly Performance
Earlier in April, Conagra unveiled fiscal third-quarter financials that fell short of market expectations. The packaged foods company delivered earnings per share of $0.39, one cent below the analyst consensus of $0.40. Revenue reached $2.79 billion, marginally surpassing the anticipated $2.76 billion.
However, the modest revenue beat provided little relief. Sales declined 1.9% on a year-over-year basis, while EPS in the prior-year quarter stood at $0.51 — representing a significant contraction. Management also trimmed its full-year projections, citing challenging macroeconomic conditions and stubborn inflationary headwinds.
Shares have slumped 17% since the start of 2026. By comparison, the S&P 500 has advanced 4.2% during the identical timeframe.
Wall Street Maintains Conservative Posture
Analyst community sentiment remains subdued. This Thursday, Morgan Stanley reduced its price objective on CAG to $15 from a previous $17, though the firm retained its “equal weight” designation. That revised target suggests merely 3.6% potential appreciation from Wednesday’s closing level.
Morgan Stanley’s adjustment followed similar moves from peers. JPMorgan trimmed its target from $19 to $17 in March. Both TD Cowen and Deutsche Bank moved to $14 targets. Stifel implemented a cut to $15 this week.
MarketBeat’s aggregated analyst data reveals 1 Buy recommendation, 13 Hold ratings, and 4 Sell calls, producing a $15.80 consensus price target and an overall “Reduce” classification.
CAG began Thursday’s session at $14.49. The stock’s 50-day moving average rests at $16.75 while the 200-day moving average sits at $17.38, both substantially above current trading levels.
One noteworthy metric: CAG presently offers approximately a 9% dividend yield, representing the highest yield among all S&P 500 constituents. The benchmark’s average dividend yield for paying companies is 2.3%.
Institutional stakeholders control 83.75% of outstanding shares. Several smaller investment firms have modestly expanded their positions in recent reporting periods, though the additions were limited in magnitude.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
